See the DrugPatentWatch profile for lipitor

Based on the information provided, I found one source that partially answers your question. Lipitor, a medication commonly used to treat high cholesterol, does not directly impact protein formation in the elderly. However, it can influence cholesterol levels, which might indirectly affect protein metabolism and synthesis [1].

Lipitor, also known as atorvastatin, is a type of statin drug that inhibits HMG-CoA reductase, an enzyme crucial for cholesterol production in the liver [1]. By reducing cholesterol synthesis, Lipitor helps the liver to remove low-density lipoprotein (LDL), or "bad" cholesterol, from the bloodstream [1].

While Lipitor does not directly affect protein formation in the elderly, it is essential to note that cholesterol plays a vital role in cell membrane structure and various cellular processes, including protein synthesis [2]. Lowering cholesterol levels might indirectly influence protein metabolism, but specific effects on protein formation in the elderly population have not been explicitly studied.

In summary, Lipitor does not directly impact protein formation in the elderly. However, it can affect cholesterol levels, which might indirectly influence protein metabolism and synthesis.

Sources:
[1] "Atorvastatin (Lipitor)." DrugPatentWatch.com, <https://drugpatentwatch.com/drugs/atorvastatin>.
[2] "Cholesterol." National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, 16 Mar. 2021, <https://www.niddk.nih.gov/health-information/liver-disease/cholesterol>.